| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $273.82 | $1,642,914.84 | -5.0% | -15.0% | -16.3% | |
| Jan 5, 2023 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | Chief Executive Officer | Sell | 110,962 | $12.07 | $1,339,311.34 | -13.5% | -15.0% | +0.3% | |
| Jan 5, 2023 | PCRX Pacira Biosciences, Inc. | Molloy Anthony74 | Chief Lgl &Compliance Officer | Sell | 704 | $38.49 | $27,093.95 | -1.8% | +6.2% | -11.0% | |
| Jan 5, 2023 | BTAI Bioxcel Therapeutics, Inc. | Nandabalan Krishnan75 | Director, 10% Owner | Sell | 60,000 | $22.01 | $1,320,875.99 | -85.0% | -23.3% | -87.4% | |
| Jan 4, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $272.77 | $4,364,263.81 | -48.8% | -16.7% | -15.7% | |
| Jan 3, 2023 | NBIX Neurocrine Biosciences Inc | Pops Richard F57 | Director | Sell | 15,000 | $119.20 | $1,788,045.00 | -33.7% | -16.0% | +10.5% | |
| Jan 3, 2023 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 12,345 | $6.50 | $80,242.50 | -4.1% | +63.1% | +43.2% | |
| Jan 3, 2023 | UTHR United Therapeutics Corp | Olian Judy D.60 | Director | Sell | 1,150 | $276.26 | $317,699.00 | -15.0% | -17.6% | -16.5% | |
| Jan 3, 2023 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 1,000 | $276.26 | $276,260.00 | -26.1% | -17.6% | -16.5% | |
| Jan 3, 2023 | NBIX Neurocrine Biosciences Inc | Sherwin Stephen A | Director | Sell | 30,000 | $118.86 | $3,565,728.00 | -37.4% | -16.0% | +10.5% | |
| Jan 3, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $27.94 | $13,971.00 | -0.6% | +35.2% | +116.5% | |
| Jan 3, 2023 | UTHR United Therapeutics Corp | Sullivan Louis W62 | Director | Sell | 700 | $276.26 | $193,382.00 | -5.4% | -17.6% | -16.5% | |
| Dec 30, 2022 | TXMD Therapeuticsmd, Inc. | Rubric Capital Management LP | 10% Owner | Sell | 29,000 | $1,333.00 | $38,657,000.00 | -100% | -33.8% | -59.7% | |
| Dec 30, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $276.05 | $4,416,791.81 | -34.4% | -21.2% | -20.9% | |
| Dec 29, 2022 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 5,000 | $275.99 | $1,379,950.00 | -68.0% | -21.3% | -20.3% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Adkins William | Former Director | Sell | 995 | $1.61 | $1,596.98 | -0.5% | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Rich Tyvin | Chief Medical Officer | Sell | 1,414 | $1.60 | $2,269.47 | -36.8% | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Dritschilo Peter | President And COO | Sell | 3,820 | $1.61 | $6,131.10 | -36.8% | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Vander Hoek Michael | Chief Financial Officer | Sell | 2,243 | $1.61 | $3,600.02 | -36.8% | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Richards Steven M | Director | Sell | 995 | $1.61 | $1,596.98 | -36.8% | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Jung Mira | Chief Scientific Officer | Sell | 328 | $1.60 | $526.44 | - | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Senanayake Chris | Director | Sell | 1,626 | $1.61 | $2,609.73 | -36.8% | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Brown Milton | Director | Sell | 995 | $1.61 | $1,596.98 | - | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Jacobs Bette | Director | Sell | 4,366 | $1.61 | $7,007.43 | -12.3% | -24.6% | -72.8% | |
| Dec 29, 2022 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Dritschilo Anatoly | CEO And Chairman | Sell | 8,372 | $1.61 | $13,437.06 | -0.8% | -24.6% | -72.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.